The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,101–9,200 of 31,469
The Taq1B‐variant in the Cholesteryl Ester–Transfer Protein Gene and the Risk of Metabolic Syndrome
Sandhofer, A., Tatarczyk, T., Laimer, M. W., Ritsch, A., Kaser, S., Paulweber, B., Ebenbichler, C. F., & Patsch, J. R. (2008) · Obesity · doi:10.1038/oby.2007.130 · Cited by 40
Park, S., Hong, S. M., & Sung, S. R. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.12.018 · Cited by 40
Antoine, H. J., Pall, M., Trader, B. C., Chen, Y. I., Azziz, R., & Goodarzi, M. O. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.10.006 · Cited by 40
PPAR-γ2 Pro12Ala Variant Is Associated with Greater Insulin Sensitivity in Childhood Obesity
Buzzetti, R., Petrone, A., Caiazzo, A. M., Alemanno, I., Zavarella, S., Capizzi, M., Mein, C. A., Osborn, J., Vania, A., & Mario, U. D. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000147728.62185.21 · Cited by 39
Rhee, E., Lee, W., Yoon, K., Yoo, S. J., Lee, I. K., Baik, S. H., Kim, Y. K., Lee, M. ‐., Park, K. S., Park, J. Y., et al. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01303.x · Cited by 40
Laguna, M., Aznar, S., Lara, M. T., Lucía, A., & Ruiz, J. R. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.10.002 · Cited by 43
Pérez‐Martínez, P., Pérez-Caballero, A. I., García‐Ríos, A., Yubero‐Serrano, E. M., Camargo, A., Gómez-Luna, M. J., Marı́n, C., Gómez-Luna, P., Dembinska-Kiec, A., Rodríguez-Cantalejo, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043390 · Cited by 40
Qi-Gong Mind–Body Therapy and Diabetes Control
Liu, X., Miller, Y. D., Burton, N. W., Chang, J.-H., & Brown, W. J. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.04.007 · Cited by 45
Mahadik, S. R., Deo, S. S., & Mehtalia, S. D. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0034 · Cited by 40
Adiponectin Predicts Insulin Resistance But Not Endothelial Function in Young, Healthy Adolescents
Singhal, A., Jamieson, N. B., Fewtrell, M. S., Deanfield, J. E., Lucas, A., & Sattar, N. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0131 · Cited by 39
Insulin secretion is decreased in non‐diabetic individuals with hypomagnesaemia
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1206 · Cited by 40
Gravholt, C. H., Hjerrild, B., Næraa, R. W., Engbaek, F., Mosekilde, L., & Christiansen, J. S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02270.x · Cited by 41
Thyagarajan, B., Jacobs, D. R., Smith, L. J., Kalhan, R., Gross, M. D., & Sood, A. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-176 · Cited by 40
Willemse, P.-P. M., van der Meer, R. W., Burggraaf, J., van Elderen, S. G. C., de Kam, M. L., Roos, A., Lamb, H. J., & Osanto, S. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.819116 · Cited by 40
Donatelli, F., Vavassori, A., Bonfanti, S., Parrella, P., Lorini, F. L., Fumagalli, R., & Carli, F. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000261506.48816.5c · Cited by 40
Fegan, P. G., Shore, A., Mawson, D., Tooke, J., & MacLeod, K. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01719.x · Cited by 42
Barazzoni, R., Cappellari, G. G., Semolic, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101590 · Cited by 40
Cohen, O., Epstein, G., Weisz, B., Homko, C., & Sivan, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02519.x · Cited by 41
Increased Prevalence of Metabolic Syndrome in Non-Obese Asian Indian—An Urban-Rural Comparison
Mahadik, S. R., Deo, S. S., & Mehtalia, S. D. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.0029 · Cited by 40
Paraoxonase 1 and oxidative stress in paediatric non‐alcoholic steatohepatitis
Desai, S. S., Baker, S. S., Liu, W., Moya, D. A., Browne, R. W., Mastrandrea, L. D., Baker, R. D., & Zhu, L. (2013) · Liver International · doi:10.1111/liv.12308 · Cited by 40
Simmons, J. H., Chow, E. J., Koehler, E., Esbenshade, A. J., Smith, L., Sanders, J. E., & Friedman, D. L. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22949 · Cited by 41
Çekmez, F., Canpolat, F. E., Pirgon, Ö., Çetınkaya, M., Aydınöz, S., Süleymanoğlu, S., İpçioğlu, O. M., & Sarıcı, S. Ü. (2011) · Cytokine · doi:10.1016/j.cyto.2011.06.007 · Cited by 39
Kang, Y. S., Song, H. K., Lee, M., Ko, G. J., & Cha, D. R. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.020 · Cited by 40
Jänis, M. T., Siggins, S., Tahvanainen, E., Vikstedt, R., Silander, K., Metso, J., Aromaa, A., Taskinen, M., Olkkonen, V. M., Jauhiainen, M., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400250-jlr200 · Cited by 41
Yang, N., Liu, X., Ding, E. L., Xu, M., Wu, S., Liu, L., Sun, X., & Hu, F. B. (2009) · Journal of Nutrition · doi:10.3945/jn.109.104406 · Cited by 42
Determining the relationship between dietary carbohydrate intake and insulin resistance
McClenaghan, N. H. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005109 · Cited by 42
Sentinelli, F., Romeo, S., Maglio, C., Incani, M., Burza, M. A., Scano, F., Coccia, F., Cossu, E., Leonetti, F., & Baroni, M. G. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-93 · Cited by 39
Packianathan, I., Sheikh, M., Boniface, D. R., & Finer, N. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00451.x · Cited by 40
Amato, M. C., Galluzzo, A., Merlino, S., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02290 · Cited by 40
Genetic variants of FOXA2: risk of type 2 diabetes and effect on metabolic traits in North Indians
Tabassum, R., Chavali, S., Dwivedi, O. P., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0335-6 · Cited by 40
Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis
Hayashi, F. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i40.5759 · Cited by 40
Araki, T., Emoto, M., Teramura, M., Yokoyama, H., Mori, K., Hatsuda, S., Maeno, T., Shinohara, K., Koyama, H., Shoji, T., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.008 · Cited by 40
Mizuno, T., Matsui, H., Imamura, A., Numaguchi, Y., Sakai, K., Murohara, T., & Okumura, K. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.10.035 · Cited by 40
Madarász, E., Tamás, G., Tabák, Á. G., & Kerényi, Z. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.001 · Cited by 41
Paternal Metabolic and Cardiovascular Risk Factors for Fetal Growth Restriction
Hillman, S. L., Peebles, D., & Williams, D. J. (2013) · Diabetes Care · doi:10.2337/dc12-1280 · Cited by 41
Mangge, H., Baumgartner, B. G., Zelzer, S., Prüller, F., Schnedl, W. J., Reininghaus, E. Z., Haybaeck, J., Lackner, C., Stauber, R. E., Aigner, E. S., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13232 · Cited by 40
The UCP1 Gene Polymorphism A-3826G in Relation to DM2 and Body Composition in Czech Population
Šrámková, D., Krejbichova, S., Včelák, J., Vaňková, M., Šamalíková, P., Hill, M., Kvasničková, H., Dvořáková, K., Vondra, K., Hainer, V., et al. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-977732 · Cited by 40
Hagobian, T. A., & Braun, B. (2006) · Metabolism · doi:10.1016/j.metabol.2005.09.017 · Cited by 39
Fujikawa, R., Okubo, M., Egusa, G., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00241-8 · Cited by 40
Gong, H., Wang, Z., Jiang, H., Fang, N., Li, J., Shang, Y., Zhang, Y. L., Zhong, M., & Zhang, W. (2009) · Diabetes Care · doi:10.2337/dc09-0061 · Cited by 40
Hanssens, L. S., VANWINKEL, R., Wampers, M., VANEYCK, D., Scheen, A. J., Reginster, J., Collette, J., Peuskens, J., & DEHERT, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.008 · Cited by 40
Won, J. C., Park, C., Lee, W., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.4.695 · Cited by 40
Vaspin and C-reactive protein levels in hyperemesis gravidarum.
Üstün, Y. E., Tonguc, E. A., Var, T., et al. (2013) · PubMed · Cited by 40
Di-(2-ethylhexyl)-phthalate induces glucose metabolic disorder in adolescent rats
Xu, J., Zhou, L., Wang, S., Zhu, J. H., Liu, T., Jia, Y., Sun, D., Chen, H., Wang, Q., Xu, F., et al. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-0738-z · Cited by 40
Frontini, M., Srinivasan, S. R., Xu, J.-H., & Berenson, G. S. (2004) · BMC Pediatrics · doi:10.1186/1471-2431-4-22 · Cited by 40
Aas, A., Seljeflot, I., Torjesen, P. A., Diep, L. M., Thorsby, P. M., & Birkeland, K. I. (2006) · Diabetologia · doi:10.1007/s00125-006-0205-8 · Cited by 40
Gazzaruso, C., Giordanetti, S., Manna, A. L., Celsa, M., Amici, E., Turpini, C., Catona, A., & Fratino, P. (2002) · Obesity Surgery · doi:10.1381/096089202320995673 · Cited by 40
Romon, M., Gomila, S., Hincker, P., Soudan, B., & Dallongeville, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1050 · Cited by 40
Yenicesu, M., Yılmaz, M. İ., Çağlar, K., et al. (2005) · Nephron Clinical Practice · doi:10.1159/000083929 · Cited by 40
Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD
Lin, S., Lin, Y., Kuo, S., Hsu, Y., & Hung, Y.-J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00844-8 · Cited by 39
Derosa, G., Gaddi, A. V., Piccinni, M. N., SALVADEO, S. A. T., Ciccarelli, L., Fogari, E., Ghelfi, M., Ferrari, I., & Cicero, A. F. G. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00480.x · Cited by 40
Sumino, H., Ichikawa, S., Itoh, H., Utsugi, T., Ohyama, Y., Umeda, M., Nakamura, T., Kanda, T., Mizunuma, H., Tomono, S., et al. (2003) · Hormone Research in Paediatrics · doi:10.1159/000072525 · Cited by 40
Howard, B. V., Horn, L. V., Hsia, J. A., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S. W., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000224659.41638.7d · Cited by 42
Djoussé, L., Pankow, J. S., Arnett, D. K., Zhang, Y., Hong, Y., Province, M. A., & Ellison, R. C. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90052-8 · Cited by 40
McGavock, J., Mandic, S., Lewanczuk, R. Z., Koller, M., Muhll, I. V., Quinney, A., Taylor, D. A., Welsh, R. C., & Haykowsky, M. J. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-3 · Cited by 40
Forst, T. M., Karagiannis, E., Lübben, G., Hohberg, C., Schöndorf, T., Dikta, G., Drexler, M., Morcos, M., Dänschel, W., Borchert, M., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.006 · Cited by 40
PAI-1 in human hypertension: relation to hypertensive groups
Srikumar, N., Brown, N. J., Hopkins, P. N., Jeunemaı̂tre, X., Hunt, S. C., Vaughan, D. E., & Williams, G. H. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02952-7 · Cited by 40
James, A. P., Watts, G. F., & Mamo, J. C. L. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00407.x · Cited by 40
Takahashi, N., Anan, F., Nakagawa, M., Yufu, K., Ooie, T., Nawata, T., Shigematsu, S., Hara, M., Saikawa, T., & Yoshimatsu, H. (2004) · Metabolism · doi:10.1016/j.metabol.2004.03.024 · Cited by 38
Giacco, R., Clemente, G., Busiello, L., Lasorella, G., Rivieccio, A., Rivellese, A. A., & Riccardi, G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802589 · Cited by 41
Urdea, M. S., Kolberg, J. A., Wilber, J. C., Gerwien, R. W., Moler, E. J., Rowe, M. W., Jorgensen, P., Hansen, T. F., Pedersen, O. B., Jørgensen, T., et al. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300422 · Cited by 40
Fraticelli, F., Celentano, C., Zecca, I. A., Di Vieste, G., Pintaudi, B., Liberati, M., Franzago, M., Di Nicola, M., & Vitacolonna, E. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1157-4 · Cited by 39
Esfahanian, F., Zamani, M. M., Heshmat, R., & Moini nia, F. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.02051.x · Cited by 38
Diet quality and osteosarcopenic obesity in community-dwelling adults 50 years and older
Kim, J., Lee, Y., Kye, S., Chung, Y.-S., Kim, J.-H., Chon, D., & Lee, K. E. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.08.007 · Cited by 37
Probiotic antigens stimulate hepatic natural killer T cells
Liang, S., Webb, T., & Li, Z. (2014) · Immunology · doi:10.1111/imm.12180 · Cited by 39
Kim, T. H., Carroll, J. E., An, S. K., Seeman, T. E., Namkoong, K., & Lee, E. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.07.023 · Cited by 39
Jamar, G., Almeida, F. R. D., Gagliardi, A., Sobral, M. R., Ping, C. T., Sperandio, E., Romiti, M., Arantes, R., & Dourado, V. Z. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0358280417 · Cited by 38
Hivert, M.-F., Christophi, C. A., Franks, P. W., Jablonski, K. A., Ehrmann, D. A., Kahn, S. E., Horton, E. S., Pollin, T. I., Mather, K. J., Perreault, L., et al. (2016) · Diabetes · doi:10.2337/db15-0950 · Cited by 38
Madjd, A., Taylor, M. A., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12793 · Cited by 39
“Insulin resistance was evaluated by homeostasis model assessment of insulin resistance (HOMA-IR).(21) Glycated hemoglobin (HbA1c) was measured by a colorimetric method after an initial separation by ion exchange chromatography (Biosystem, Barcelona, Spain).”
MethodPeterson, M. D., Liu, D., Gordish-Dressman, H., Hubal, M. J., Pistilli, E., Angelopoulos, T. J., Clarkson, P. M., Moyna, N. M., Pescatello, L. S., Seip, R. L., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.257 · Cited by 39
Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals
Ho, J. E., Arora, P., Walford, G. A., Ghorbani, A., Guanaga, D. P., Dhakal, B. P., Nathan, D. I., Buys, E. S., Florez, J. C., Newton‐Cheh, C., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001001 · Cited by 39
Neural and Endocrine Correlates of Early Life Abuse in Youth With Depression and Obesity
Sun, K., Watson, K. T., Angal, S., Bakkila, B. F., Gorelik, A. J., Leslie, S. M., Rasgon, N., & Singh, M. K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00721 · Cited by 39
Cederholm, J., & Zethelius, B. (2019) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2019.1680583 · Cited by 42
Chen, L., Huang, M., Shyu, Y., & Chien, R. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12395 · Cited by 42
Barchetta, I., Dule, S., Bertoccini, L., Cimini, F. A., Sentinelli, F., Bailetti, D., Marini, G., Barbonetti, A., Loche, S., Cossu, E., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01612-6 · Cited by 40
Sato, F., Nakamura, Y., Kayaba, K., & Ishikawa, S. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.05.002 · Cited by 40
Queiroz, J. D. N., Macedo, R. C. O., dos Santos, G. C., Munhoz, S. V., Machado, C. L. F., Leal-Menezes, R., Nascimento, E. M., Moritz, C. E. J., Pinto, R. S., Tinsley, G. M., et al. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522001581 · Cited by 42
METS-IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents
Widjaja, N. A., Irawan, R., Hanindita, M. H., Ugrasena, I. D. G., & Handajani, R. (2023) · The Journal of Medical Investigation · doi:10.2152/jmi.70.7 · Cited by 39
Birth size, growth trajectory and later cardio-metabolic risk
Cauzzo, C., Chiavaroli, V., Valerio, S. D., & Chiarelli, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1187261 · Cited by 46
Coordinated human sleeping brainwaves map peripheral body glucose homeostasis
Vallat, R., Shah, V. D., & Walker, M. P. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101100 · Cited by 39
Cornejo-Pareja, I. M., Amiar, M. R., Ocaña-Wilhelmi, L., Soler-Humanes, R., Arranz‐Salas, I., Garrido‐Sánchez, L., Gutiérrez‐Repiso, C., & Tinahones, F. J. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-023-02075-7 · Cited by 40
Vitamins C, E, and β-Carotene and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
Lampousi, A., Lundberg, T., Löfvenborg, J. E., & Carlsson, S. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100211 · Cited by 41
Linder, K., Springer, L., Machann, J., Schick, F., Fritsche, A., Häring, H., Blumenstock, G., Ranke, M. B., Stefan, N., Binder, G., et al. (2013) · Obesity · doi:10.1002/oby.20685 · Cited by 39
Schusterová, I., Leenen, F. H. H., Jurko, A., Sabol, F., & Takacova, J. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00134.x · Cited by 39
Food consumption and cardiovascular risk factors in E uropean children: the IDEFICS study
Bel‐Serrat, S., Mouratidou, T., Börnhorst, C., Peplies, J., Henauw, S. D., Mårild, S., Molnár, D., Siani, A., Tornaritis, M. J., Veidebaum, T., et al. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00107.x · Cited by 39
Järvelä, L. S., Niinikoski, H., Heinonen, O. J., Lähteenmäki, P. M., Arola, M. O., & Kemppainen, J. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24565 · Cited by 39
Chavali, S., Mahajan, A., Tabassum, R., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.83 · Cited by 39
Mason, C. E., Foster‐Schubert, K. E., Imayama, I., Xiao, L., Kong, A., Campbell, K. L., Duggan, C. R., Wang, C.-Y., Alfano, C. M., Ulrich, C. M., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.06.012 · Cited by 38
Kim, M. J., Hwang, J. H., Ko, H. J., Na, H. B., & Kim, J. H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.04.001 · Cited by 43
Yamamoto, M., & Otsuki, M. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.007 · Cited by 39
Mingorance, C., Duluc, L., Chalopin, M., Simard, G., Ducluzeau, P., Herrera, M. D., de Sotomayor, M. Á., & Andriantsitohaina, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034268 · Cited by 39
Assessment of Pregestational Insulin Resistance as a Risk Factor of Preeclampsia
Valdés, E., Sepúlveda-Martínez, Á., Manukian, B., & Parra-Cordero, M. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000357944 · Cited by 41
Wu, C., Yang, C., Lin, J., Hsieh, H., Chiu, F., Chen, J.-J., Lee, J., Huang, S., Li, H., Chiang, F., et al. (2011) · Obesity · doi:10.1038/oby.2011.30 · Cited by 39
Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery
Heath, M. L., Kow, L., Slavotinek, J., Valentine, R., Toouli, J., & Thompson, C. H. (2009) · Metabolism · doi:10.1016/j.metabol.2008.05.021 · Cited by 38
Morimoto, A., Tatsumi, Y., Soyano, F., Miyamatsu, N., Sonoda, N., Godai, K., Ohno, Y., Noda, M., & Deura, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105827 · Cited by 39
Shih, K., Janckila, A. J., Kwok, C., Ho, L., Chou, Y., & Chao, T.-Y. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.035 · Cited by 40
Sedentary behaviour and clustered metabolic risk in adolescents: The HELENA study
Rey-López, J. P., Bel‐Serrat, S., Santaliestra-Pasías, A. M., de Moraes, A. C. F., Vicente‐Rodríguez, G., Ruiz, J. R., Artero, E. G., Martínez‐Gómez, D., Gottrand, F., Henauw, S. D., et al. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.06.006 · Cited by 37
Increased circulating myostatin in patients with type 2 diabetes mellitus
Wang, F., Liao, Y., Li, X., Ren, C., Cheng, C., & Ren, Y. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0092-9 · Cited by 39
Heneghan, H., Huang, H., Kashyap, S. R., Gornik, H. L., McCullough, A. J., Schauer, P. R., Brethauer, S. A., Kirwan, J. P., & Kasumov, T. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.018 · Cited by 39
Lee, K., & Yang, J. H. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0153 · Cited by 39
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
